Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502

FDA recall notice · announced December 28, 2016 · Town And Country Compounding And Consultation Services

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502

Reason for recall

Non-Sterility; microbial contamination identified as Bacillus circulans

Notes

Distribution: MA, NY, NJ & FL; Canada
Lot/code information: lot #07172016@1, exp 1/13/2017
Quantity: 12 vials
Status: Terminated
Products in this recall event:
- Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502 (D-0228-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.